Rupali Bhave
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Papers in
- Hematology 13
- Acute Myeloid Leukemia Research 9
- Chronic Myeloid Leukemia Treatments 6
-
- Histone Deacetylase Inhibitors Research 3
- Protein Degradation and Inhibitors 2
- Nuclear Structure and Function 2
- Co-authors
- Timothy S. Pardee (13 shared papers)Bayard L. Powell (12 shared papers)Leslie R. Ellis (12 shared papers)Maria R. Baer (2 shared papers)Richard M. Stone (2 shared papers)Min Fang (2 shared papers)Jae H. Park (2 shared papers)Ibrahim Aldoss (2 shared papers)
- Journals
- Blood (11 papers)Cell stem cell (1 paper)Cancer (1 paper)Annals of Hematology (1 paper)Leukemia Research (1 paper)
- Partner nations
- United StatesItalyChina
In The Last Decade
Rupali Bhave
16 papers receiving 233 citations
Peers
Comparison fields: 5 of 44
- Hematology 104
- Geriatrics and Gerontology 12
- Public Health, Environmental and Occupational Health 87
- Oncology 66
- Genetics 23
Countries citing papers authored by Rupali Bhave
This map shows the geographic impact of Rupali Bhave's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rupali Bhave with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rupali Bhave more than expected).
Fields of papers citing papers by Rupali Bhave
This network shows the impact of papers produced by Rupali Bhave. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rupali Bhave. The network helps show where Rupali Bhave may publish in the future.
Co-authors
The 25 scholars most cited alongside Rupali Bhave, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia | 2022 | 57 |
| 2 | 2020 | 37 | |
| 3 | 2017 | 36 | |
| 4 | 2018 | 33 | |
| 5 | 2022 | 31 | |
| 6 | 2020 | 8 | |
| 7 | 2020 | 5 | |
| 8 | 2021 | 5 | |
| 9 | 2018 | 4 | |
| 10 | 2021 | 4 | |
| 11 | 2020 | 4 | |
| 12 | 2019 | 3 | |
| 13 | 2021 | 3 | |
| 14 | 2021 | 2 | |
| 15 | 2017 | 1 | |
| 16 | 2017 | 1 | |
| 17 | 2023 | 0 | |
| 18 | 2023 | 0 | |
| 19 | 2024 | 0 |
About Rupali Bhave
Rupali Bhave is a scholar working on Hematology, Molecular Biology, Public Health, Environmental and Occupational Health, Genetics and Oncology, having authored 19 papers that have together received 234 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (9 papers), Chronic Myeloid Leukemia Treatments (6 papers), Acute Lymphoblastic Leukemia research (5 papers), Histone Deacetylase Inhibitors Research (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Neutropenia and Cancer Infections (3 papers), Protein Degradation and Inhibitors (2 papers) and Nuclear Structure and Function (2 papers). The work is most often cited by research in Hematology (104 citations), Geriatrics and Gerontology (12 citations), Public Health, Environmental and Occupational Health (87 citations), Oncology (66 citations) and Genetics (23 citations). Rupali Bhave has collaborated with scholars based in United States, Italy and China. Frequent co-authors include Timothy S. Pardee, Bayard L. Powell, Leslie R. Ellis, Maria R. Baer, Richard M. Stone, Min Fang, Jae H. Park, Ibrahim Aldoss, Mark R. Litzow and Rebecca B. Klisovic. Their work appears in journals such as Blood, Cell stem cell, Cancer, Annals of Hematology and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.